News

Novavax has shared positive preliminary results from a real-world study of its JN.1-adapted COVID-19 vaccine. The SHIELD-Utah ...
The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley, Vice President and General ...
The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...
The European Commission has granted marketing authorisation for Leqembi (lecanemab), making it the first therapy in the EU to slow the progression of early Alzheimer’s disease.
Oncodesign Services has announced the appointment of Aidan Synnott as its new Chief Executive Officer (CEO). Synnott has more ...
Real-world data from the University of Catania, Italy, suggest that Pepaxti, a treatment for relapsed, refractory multiple myeloma (RRMM), is effective and well tolerated in heavily pretreated ...